Clinical trials
Alzheimer Disease trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
132 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2006 | 3 |
| 2007 | 5 |
| 2008 | 10 |
| 2009 | 9 |
| 2010 | 6 |
| 2011 | 2 |
| 2012 | 10 |
| 2013 | 6 |
| 2014 | 7 |
| 2015 | 9 |
| 2016 | 8 |
| 2017 | 5 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 5 |
| 2021 | 7 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 10 |
| 2025 | 12 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 60 |
| Terminated | 35 |
| Recruiting | 19 |
| Active, not recruiting | 14 |
| Not yet recruiting | 2 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 31 |
| Pfizer | 12 |
| Hoffmann-La Roche | 11 |
| Eisai Co., Ltd. | 8 |
| Biogen | 6 |
| Novartis Pharmaceuticals | 6 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 6 |
| Bristol-Myers Squibb | 5 |
| Eisai Inc. | 4 |
| Janssen Pharmaceutical K.K. | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 132 |
| Dementia | 27 |
| Cognitive Dysfunction | 20 |
| Brain Diseases | 8 |
| Plaque, Amyloid | 8 |
| Tauopathies | 8 |
| Nervous System Diseases | 7 |
| Neurodegenerative Diseases | 7 |
| Central Nervous System Diseases | 6 |
| Mental Disorders | 6 |
Trials
Showing 51 to 75 of 132. Each trial links to its page on Pharma Observatory.
32 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.